Format

Send to

Choose Destination
Clin Infect Dis. 2019 Aug 15. pii: ciz787. doi: 10.1093/cid/ciz787. [Epub ahead of print]

Emergence of Delafloxacin-Resistant Staphylococcus aureus in Brooklyn, NY.

Author information

1
Department of Internal Medicine, Division of Infectious Diseases, SUNY-Downstate Medical Center, Brooklyn, NY.

Abstract

Delafloxacin is an option for infections due to methicillin-resistant Staphylococcus aureus. In 2017, 22% of isolates from seven hospitals in Brooklyn, NY were nonsusceptible to delafloxacin. Isolates belonging to ST105, a strain associated with healthcare-related infections, predominated. Resistance was also found in ST8, a strain (USA300) associated with community-associated infections.

KEYWORDS:

Staphylococcus aureus ; Delafloxacin; antibiotic resistance

PMID:
31412357
DOI:
10.1093/cid/ciz787

Supplemental Content

Full text links

Icon for Silverchair Information Systems
Loading ...
Support Center